Systemic Analysis and Review of Nivolumab-ipilimumab Combination as a Rescue Strategy for Renal Cell Carcinoma After Treatment With Anti–PD-1/PD-L1 Therapy
Lucía Carril-Ajuria, David Lora, Alberto Carretero-González, Maricruz Martín-Soberón, Patricia Rioja, Daniel Castellano, Guillermo de Velasco
Topics & Concepts
NivolumabIpilimumabMedicineInternal medicineOncologyRenal cell carcinomaAdverse effectSalvage therapyContext (archaeology)RegimenClinical trialIncidence (geometry)CancerChemotherapyImmunotherapyBiologyPaleontologyOpticsPhysicsCancer Immunotherapy and BiomarkersRenal cell carcinoma treatmentPancreatic and Hepatic Oncology Research